Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
View allAlzheimer's DiseaseAnavex2-73EventsNews ReleasesPDDPIPELINEPressRett Syndrome

Anavex Reports Predicted Clinical Effect for ANAVEX 2-73 in Computer Simulation Model of Alzheimer’s Disease

November 18, 2013

Anavex Announces Positive Data for ANAVEX 2-73 in Alzheimer’s Disease

November 12, 2013

Chronic treatment with the tetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic cholinergic and sigma-1 ligand, alleviates pathology in Tg2576 mice, a transgenic Alzheimer’s disease model.

November 11, 2013

Blockade of Tau Hyperphosphorylation and Ab1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and r1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease.

November 11, 2013

Anavex CEO to Present Clinical Prediction Data for ANAVEX 2-73 at CNS Summit 2013

November 7, 2013

Anavex Reports ANAVEX 2-73 Blocks Tau and Amyloid-Beta Proteins in a Preclinical Model of Alzheimer’s Disease

November 4, 2013

Anavex to Present Data for ANAVEX 2-73 at Society for Neuroscience 2013 Annual Meeting

October 29, 2013

Anavex Encouraged by New Sigma-1 Receptor Study That May Explain Therapeutic Efficacy of ANAVEX 2-73 for Alzheimer’s Disease

October 22, 2013

Anavex Comments on Newly Released World Alzheimer Report 2013

September 23, 2013

Anavex to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

September 3, 2013

Anavex to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

September 3, 2013

Anavex CEO Writes Letter to Shareholders

August 15, 2013
1
234567891011121314151617181920212223
…2425262728…
29303132333435363738394041
42

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top